Switch to:

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Dr. Clay B. Siegall,PhDPresident and CEO532,7340.38%2016-08-22
Franklin M. BergerN/A204,7200.15%2014-02-21
Todd E. SimpsonCFO191,4450.14%2016-08-22
Dr. Marc E. Lippman,M.D.N/A132,350less than 0.1%2016-05-20
Dr. Vaughn B. Himes,PhDEVP, Proc Svcs & Tech Ops108,779less than 0.1%2016-08-22
Dr. Felix J. Baker,PhDDirector, 10% Owner107,504less than 0.1%2016-05-20
Jonathan G. DrachmanCMO & EVP, R & D84,255less than 0.1%2016-08-22
Christopher S. BoernerN/A72,358less than 0.1%2014-08-24
Eric L. DobmeierCOO67,525less than 0.1%2016-08-22
Tim J. CarrollN/A62,861less than 0.1%2005-05-03

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Share Ownership Details
DOBMEIER ERICCOO2016-08-23Sell12,58958,767$48604.27-658,767 (Direct)
Cline Darren SEVP, Commercial2016-08-22Sell1,77440,973$46.5982.65-3.1640,973 (Direct)
DOBMEIER ERICCOO2016-08-22Sell5,41167,525$46.59252.1-3.1667,525 (Direct)
DRACHMAN JONATHAN GCMO & EVP, R & D2016-08-22Sell3,99184,255$46.59185.94-3.1684,255 (Direct)
HIMES VAUGHN BEVP, Proc Svcs & Tech Ops2016-08-22Sell3,991108,779$46.59185.94-3.16108,779 (Direct)
SIEGALL CLAY BPresident and CEO
(Click for the stocks that their CEOs have bought)
2016-08-22Sell23,381560,679$46.591089.32-3.16532,734 (Direct)
27,945 (by Trust)
SIMPSON TODD ECFO2016-08-22Sell3,991191,445$46.59185.94-3.16191,445 (Direct)
SIEGALL CLAY BPresident and CEO2016-08-08Sell11,660584,060$47.19550.24-4.39556,115 (Direct)
27,945 (by Trust)
SIEGALL CLAY BPresident and CEO2016-07-27Sell4,042584,060$45.2182.7-0.18556,115 (Direct)
27,945 (by Trust)
SIEGALL CLAY BPresident and CEO2016-07-06Sell7,618584,060$40.56308.9911.24556,115 (Direct)
27,945 (by Trust)
SIEGALL CLAY BPresident and CEO2016-06-06Sell22,083584,060$43.59962.63.51556,115 (Direct)
27,945 (by Trust)
Cline Darren SEVP, Commercial2016-06-02Sell3,36642,747$42.07141.617.2542,747 (Direct)
SIEGALL CLAY BPresident and CEO2016-05-27Sell48,660584,060$40.411966.3511.66556,115 (Direct)
27,945 (by Trust)
SIEGALL CLAY BPresident and CEO2016-05-24Sell8,400584,060$40.09336.7612.55556,115 (Direct)
27,945 (by Trust)
SIEGALL CLAY BPresident and CEO2016-05-17Sell7,618584,060$35.16267.8528.33556,115 (Direct)
27,945 (by Trust)
SIEGALL CLAY BPresident and CEO2016-04-25Sell800584,060$403212.8556,115 (Direct)
27,945 (by Trust)
SIEGALL CLAY BPresident and CEO2016-04-05Sell7,618584,060$36.12275.1624.92556,115 (Direct)
27,945 (by Trust)
SIEGALL CLAY BPresident and CEO2016-03-22Sell15,236584,060$35.52541.1827.03556,115 (Direct)
27,945 (by Trust)
BAKER FELIXDirector, 10% Owner2016-03-17Buy124,06547,873,417$31.853951.4741.66107,504 (Direct)
4,486,246 (See footnotes(F4,F5,F8,F9))
38,783,387 (See footnotes(F5,F6,F8,F9))
4,496,280 (See Footnotes(F4,F5,F8,F9))
BAKER FELIXDirector, 10% Owner2016-03-16Buy1,349,23747,668,558$32.143310.5140.56107,504 (Direct)
4,484,096 (See footnotes(F4,F5,F14,F15))
38,671,506 (See footnotes(F5,F6,F14,F15))
4,405,452 (See Footnotes(F4,F5,F14,F15))
BAKER FELIXDirector, 10% Owner2016-03-11Buy694,66646,212,264$32.4622548.8639107,504 (Direct)
4,351,589 (See footnotes(F4,F5,F14,F15))
37,454,776 (See footnotes(F5,F6,F14,F15))
4,298,395 (See Footnotes(F4,F5,F14,F15))
BAKER FELIXDirector, 10% Owner2016-03-08Buy502,523127,365,973$22.6611387.1799.12107,504 (Direct)
4,255,959 (See footnotes(F4,F17))
36,682,540 (See footnotes(F5,F17))
4,249,772 (See Footnotes(F4,F17))
4,265,959 (See footnotes(F9,F12,F13,F17))
36,692,540 (See footnotes(F10,F12,F14,F17))
4,281,431 (See footnotes(F13,F17))
36,830,268 (See footnotes(F14,F17))
BAKER FELIXDirector, 10% Owner2016-03-02Buy675,92244,876,220$31.7721474.0442.02107,504 (Direct)
4,221,368 (See footnotes(F4,F9))
36,367,808 (See footnotes(F5,F9))
4,179,540 (See Footnotes(F4,F9))
BAKER FELIXDirector, 10% Owner2016-02-26Buy314,50844,148,952$29.559293.7152.69107,504 (Direct)
4,154,719 (See footnotes(F4,F9))
35,758,535 (See footnotes(F5,F9))
4,128,194 (See Footnotes(F4,F9))
BAKER FELIXDirector, 10% Owner2016-02-22Buy1,001,47143,804,485$29.6329673.5952.28107,504 (Direct)
4,122,878 (See footnotes(F4,F7))
35,475,868 (See footnotes(F5,F7))
4,098,235 (See Footnotes(F4,F7))
BAKER FELIXDirector, 10% Owner2016-02-17Buy1,269,14776,210,189$30.4338620.1448.27107,504 (Direct)
3,916,805 (See footnotes(F4,F11))
33,588,605 (See footnotes(F5,F11))
4,023,889 (See Footnotes(F4,F11))
34,573,386 (See Footnotes(F5,F11))
Orwin John ADirector2016-02-12Buy2,00010,700$28.3356.6659.2710,700 (Direct)
HIMES VAUGHN BEVP, Proc Svcs & Tech Ops2015-12-15Sell40,50076,212$39.941617.5712.9776,212 (Direct)
SIEGALL CLAY BPresident and CEO2015-12-03Sell3,720584,060$39.99148.7612.83556,115 (Direct)
27,945 (by Trust)
BAKER FELIXDirector, 10% Owner2015-11-20Buy329,35837,435,632$43.9414471.992.69107,504 (Direct)
3,899,276 (See footnote)
33,428,852 (See Footnote)
SIEGALL CLAY BPresident and CEO2015-11-17Sell87,473584,060$45.43971.27-0.62556,115 (Direct)
27,945 (by Trust)
Cline Darren SSVP, Commercial2015-11-11Sell5,76937,713$45.68263.53-1.2337,713 (Direct)
BAKER FELIXDirector, 10% Owner2015-11-10Buy934,6244,006,780$42.9540142.15.05107,504 (Direct)
3,899,276 (See footnote)
DOBMEIER ERICCOO2015-11-06Sell17,45280,888$42.5741.716.1680,888 (Direct)
GRYSKA DAVID WDirector2015-11-05Sell10,00023,950$43.57435.73.5623,950 (Direct)
SIEGALL CLAY BPresident and CEO2015-11-04Sell3,718671,533$43.14160.394.59643,588 (Direct)
27,945 (by Trust)
SIEGALL CLAY BPresident and CEO2015-10-05Sell3,718639,268$41.3153.559.25611,323 (Direct)
27,945 (by Trust)
BAKER FELIXDirector, 10% Owner2015-09-15Buy5,159,4844,006,780$42.56219587.646.02107,504 (Direct)
3,899,276 (See footnote)
SIEGALL CLAY BPresident and CEO2015-09-03Sell3,718639,268$40.12149.1712.46611,323 (Direct)
27,945 (by Trust)
SIEGALL CLAY BPresident and CEO2015-08-20Sell31,754639,268$42.021334.37.38611,323 (Direct)
27,945 (by Trust)
DOBMEIER ERICCOO2015-08-20Sell8,54898,340$42.02359.197.3898,340 (Direct)
DRACHMAN JONATHAN GCMO & EVP, R & D2015-08-20Sell4,46282,724$42.02187.497.3882,724 (Direct)
Cline Darren SSVP, Commercial2015-08-20Sell2,23143,482$42.0293.757.3843,482 (Direct)
SIMPSON TODD ECFO2015-08-20Sell5,825179,874$42.02244.777.38179,874 (Direct)
HIMES VAUGHN BEVP, Proc Svcs & Tech Ops2015-08-20Sell5,99776,212$42.02251.997.3876,212 (Direct)
DOBMEIER ERICCOO2015-08-20Sell8,54898,340$42.02359.197.3898,340 (Direct)
Cline Darren SSVP, Commercial2015-08-20Sell2,23143,482$42.0293.757.3843,482 (Direct)
SIEGALL CLAY BPresident and CEO2015-08-05Sell3,718657,022$46.91174.41-3.82557,022 (Direct)
100,000 (by Trust)
SIEGALL CLAY BPresident and CEO2015-07-06Sell3,718657,022$46.94174.52-3.88557,022 (Direct)
100,000 (by Trust)
SIEGALL CLAY BPresident and CEO2015-06-03Sell3,718657,022$45.72169.99-1.31557,022 (Direct)
100,000 (by Trust)
BAKER FELIXDirector, 10% Owner2015-05-21Buy950,8864,006,780$42.4940403.156.19107,504 (Direct)
3,899,276 (See footnote)
DOBMEIER ERICCOO2015-05-08Sell17,07482,777$40.38689.4511.7482,777 (Direct)
SIEGALL CLAY BPresident and CEO2015-05-08Sell52,052657,022$40.652115.9111557,022 (Direct)
100,000 (by Trust)
BAKER FELIXDirector, 10% Owner2015-05-07Buy1,032,6643,993,080$35.5636721.5326.88107,504 (Direct)
3,885,576 (See footnote)
Cline Darren SSVP, Commercial2015-03-13Sell7,50033,135$38.65289.8816.7433,135 (Direct)
HIMES VAUGHN BEVP, Proc Svcs & Tech Ops2015-03-12Sell20,00067,209$36.6573323.1167,209 (Direct)
BAKER FELIXDirector, 10% Owner2015-03-10Buy285,0363,993,080$34.669879.3530.18107,504 (Direct)
3,885,576 (See footnote)
BAKER FELIXDirector, 10% Owner2015-03-04Buy448,8413,993,080$34.8415637.6229.51107,504 (Direct)
3,885,576 (See footnote)
BAKER FELIXDirector, 10% Owner2015-02-25Buy281,1153,993,080$33.929535.4233.02107,504 (Direct)
3,885,576 (See footnote)
SIEGALL CLAY BPresident and CEO2015-01-06Sell16,804659,710$31.8534.3741.89559,710 (Direct)
100,000 (by Trust)
BAKER FELIXDirector, 10% Owner2014-12-16Buy2,883,3783,993,080$31.8691864.4241.62107,504 (Direct)
3,885,576 (See footnote)
BAKER FELIXDirector, 10% Owner2014-12-10Buy1,247,8963,993,080$33.8242203.8433.41107,504 (Direct)
3,885,576 (See footnote)
HIMES VAUGHN BEVP, Tech. Ops. & Proc. Sci.2014-11-12Sell10,00067,209$37.52375.220.2667,209 (Direct)
BAKER FELIXDirector, 10% Owner2014-11-10Buy1,653,925493,205$34.5657159.6530.5676,997 (Direct)
416,208 (See footnote)
SIEGALL CLAY BPresident and CEO2014-09-04Sell5,600659,710$42.54238.226.06559,710 (Direct)
100,000 (by Trust)
DOBMEIER ERICCOO2014-08-25Sell4,81891,432$43.55209.823.6191,432 (Direct)
SIMPSON TODD ECFO2014-08-24Sell3,696168,699$43.55160.963.61168,699 (Direct)
SIEGALL CLAY BPresident and CEO2014-08-24Sell25,507659,710$43.551110.833.61559,710 (Direct)
100,000 (by Trust)
HIMES VAUGHN BEVP, Tech. Ops. & Proc. Sci.2014-08-24Sell3,31067,209$43.55144.153.6167,209 (Direct)
DRACHMAN JONATHAN GCMO & EVP, R & D2014-08-24Sell2,77266,481$43.55120.723.6166,481 (Direct)
BOERNER CHRISTOPHER S.Executive Vice President, Comm2014-08-24Sell1,24872,358$43.5554.353.6172,358 (Direct)
SIEGALL CLAY BPresident and CEO2014-08-12Sell11,200625,217$40.38452.2611.74525,217 (Direct)
100,000 (by Trust)
BAKER FELIXDirector, 10% Owner2014-06-13Buy216,5953,962,573$39.928646.4713.0376,997 (Direct)
3,885,576 (See footnote)
SIEGALL CLAY BPresident and CEO2014-06-10Sell11,200625,217$40.14449.5712.41525,217 (Direct)
100,000 (by Trust)
BAKER FELIXDirector, 10% Owner2014-06-09Buy546,2523,962,573$38.1620844.9818.2476,997 (Direct)
3,885,576 (See footnote)
BAKER FELIXDirector, 10% Owner2014-06-04Buy281,9633,962,573$34.869829.2329.4376,997 (Direct)
3,885,576 (See footnote)
BAKER FELIXDirector, 10% Owner2014-05-16Buy189,611467,941$34.076460.0532.4376,997 (Direct)
390,944 (See footnote)
HIMES VAUGHN BEVP, Tech. Ops. & Proc. Sci.2014-05-09Sell10,00055,519$3535028.9155,519 (Direct)
BAKER FELIXDirector, 10% Owner2014-05-09Buy488,3823,949,073$33.9616585.4532.8676,997 (Direct)
3,872,076 (See footnote)
SIEGALL CLAY BPresident and CEO2014-04-03Sell5,600955,696$43.34242.74.11955,696 (Direct)
SIEGALL CLAY BPresident and CEO2014-03-05Sell9,318955,696$52.89492.83-14.69955,696 (Direct)
BOERNER CHRISTOPHER S.SVP, Commercial2014-02-21Sell1,45246,075$54.9879.83-17.9346,075 (Direct)
DRACHMAN JONATHAN GCMO & EVP, R & D2014-02-20Sell1,24148,670$53.2566.08-15.2748,670 (Direct)
HIMES VAUGHN BEVP, Tech, Ops. & Proc. Sci.2014-02-19Sell5,08844,219$52.01264.63-13.2544,219 (Direct)
SIEGALL CLAY BPresident and CEO2014-02-18Sell100,000955,696$51.975197-13.18955,696 (Direct)
DOBMEIER ERICCOO2014-01-21Sell56,01077,833$47.922684-5.8477,833 (Direct)
DRACHMAN JONATHAN GCMO & EVP, R & D2014-01-16Sell1,20149,911$45.7554.95-1.3849,911 (Direct)
SIEGALL CLAY BPresident and CEO2014-01-02Sell1,8581,043,554$39.2772.9614.91,043,554 (Direct)
BAKER FELIXDirector, 10% Owner2013-12-16Buy407,0783,949,073$39.6616144.7113.7776,997 (Direct)
3,872,076 (See footnote)
BAKER FELIXDirector, 10% Owner2013-12-05Buy1,005,9013,949,073$43.1943444.864.4776,997 (Direct)
3,872,076 (See footnote)
SIEGALL CLAY BPresident and CEO2013-12-02Sell2,0001,024,558$41.2582.59.381,024,558 (Direct)
SIEGALL CLAY BPresident and CEO2013-11-01Sell2,0001,024,558$38.6377.2616.81,024,558 (Direct)
SIEGALL CLAY BPresident and CEO2013-10-01Sell2,0001,024,558$43.8787.742.851,024,558 (Direct)
DOBMEIER ERICCOO2013-09-10Sell42,000133,843$46.41948.8-2.76133,843 (Direct)
DOBMEIER ERICCOO2013-09-05Sell75,000135,843$42.6431985.82135,843 (Direct)
SIEGALL CLAY BPresident and CEO2013-09-03Sell102,000977,211$43.94477.82.78977,211 (Direct)
GRYSKA DAVID WDirector2013-09-03Sell10,00022,000$42.48424.86.2122,000 (Direct)
SIMPSON TODD ECFO2013-08-27Sell37,763155,395$41.451565.288.85155,395 (Direct)
SIEGALL CLAY BPresident and CEO2013-08-19Sell7,6531,124,558$40.91313.0810.291,124,558 (Direct)
SIMPSON TODD ECFO2013-08-19Sell3,328125,029$40.91136.1510.29125,029 (Direct)
DOBMEIER ERICCOO2013-08-19Sell3,328127,620$40.91136.1510.29127,620 (Direct)
HIMES VAUGHN BEVP, Tech. Ops. & Proc. Sci.2013-08-19Sell1,73646,307$40.9171.0210.2946,307 (Direct)
BOERNER CHRISTOPHER S.SVP, Commercial2013-08-19Sell22647,527$40.919.2510.2947,527 (Direct)
SIEGALL CLAY BPresident and CEO2013-08-01Sell2,0001,077,211$40.0380.0612.721,077,211 (Direct)
SIMPSON TODD ECFO2013-07-12Sell92,527113,957$37.453465.1420.48113,957 (Direct)
SIEGALL CLAY BPresident and CEO2013-07-01Sell2,0001,077,211$32.5965.1838.451,077,211 (Direct)
AKKARAJU SRINIVASDirector2013-06-14Sell5,00013,905$32.75163.7537.7713,905 (Direct)
HIMES VAUGHN BEVP, Tech. Ops. & Proc. Sci.2013-06-13Sell10,00033,643$32.11321.140.5233,643 (Direct)
SIEGALL CLAY BPresident and CEO2013-06-03Sell2,0001,077,211$33.8867.7633.181,077,211 (Direct)
AKKARAJU SRINIVASDirector2013-05-10Sell17,50010,405$37.17650.4821.3910,405 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-09Buy488,3823,949,073$33.9616585.4532.8676,997 (Direct)
3,872,076 (See footnote)
SIEGALL CLAY BPresident and CEO2013-05-01Sell2,0001,077,211$36.5873.1623.351,077,211 (Direct)
SIEGALL CLAY BPresident and CEO2013-04-01Sell2,0001,077,211$35.5371.0626.991,077,211 (Direct)
BOERNER CHRISTOPHER S.SVP, Commercial2013-03-15Sell8,50033,753$33.61285.6934.2533,753 (Direct)
DOBMEIER ERICCOO2013-03-11Sell60,000112,948$31.161869.644.8112,948 (Direct)
SIMPSON TODD ECFO2013-03-07Sell49,718113,957$30.751528.8346.73113,957 (Direct)
DOBMEIER ERICCOO2013-03-06Sell100,000122,948$29.68296852.02122,948 (Direct)
SIEGALL CLAY BPresident and CEO2013-03-05Sell95,7501,077,211$28.712748.9857.161,077,211 (Direct)
GRYSKA DAVID WDirector2013-02-25Sell10,00018,500$27.17271.766.0718,500 (Direct)
SIEGALL CLAY BPresident and CEO2013-02-01Sell2,0001,170,961$29.6159.2252.381,170,961 (Direct)
Reynolds Thomas CChief Medical Officer2013-01-28Sell7,29057,601$30.09219.3649.9557,601 (Direct)
Reynolds Thomas CChief Medical Officer2013-01-15Sell125,07957,601$283502.2161.1457,601 (Direct)
SIEGALL CLAY BPresident and CEO2013-01-04Sell8,2491,170,961$24.13199.0586.991,170,961 (Direct)
DOBMEIER ERICCOO2013-01-04Sell50,983122,846$24.951272.0380.84122,846 (Direct)
DOBMEIER ERICCOO2012-12-17Sell50,000113,829$23.7118590.38113,829 (Direct)
Reynolds Thomas CChief Medical Officer2012-12-10Sell66,58857,601$25.771715.9775.0957,601 (Direct)
Reynolds Thomas CChief Medical Officer2012-12-05Sell40,00057,601$25.591023.676.3257,601 (Direct)
Reynolds Thomas CChief Medical Officer2012-12-03Sell40,00057,601$25.411016.477.5757,601 (Direct)
SIEGALL CLAY BPresident and CEO2012-12-03Sell8,2501,170,961$25.19207.8279.121,170,961 (Direct)
Reynolds Thomas CChief Medical Officer2012-11-26Sell30,00057,601$25.34760.278.0657,601 (Direct)
Reynolds Thomas CChief Medical Officer2012-11-20Sell20,00057,601$24.9549980.8457,601 (Direct)
DOBMEIER ERICCOO2012-11-13Sell27,327101,411$23.59644.6491.27101,411 (Direct)
SIEGALL CLAY BPresident and CEO2012-11-01Sell8,2501,170,961$25.51210.4676.871,170,961 (Direct)
DOBMEIER ERICCOO2012-10-15Sell25,00069,352$25.01625.2580.4169,352 (Direct)
SIEGALL CLAY BPresident and CEO2012-10-01Sell8,2501,170,961$26.59219.3769.691,170,961 (Direct)
HIMES VAUGHN BEVP, Tech. Ops. & Proc. Sci.2012-09-10Sell10,00033,643$28.79287.956.7233,643 (Direct)
SIMPSON TODD ECFO2012-09-06Sell95,00070,762$28.52707.558.3270,762 (Direct)
Reynolds Thomas CChief Medical Officer2012-09-06Sell48,54057,601$29.751444.0751.6657,601 (Direct)
SIEGALL CLAY BPresident and CEO2012-09-04Sell8,2501,170,961$26.54218.9670.011,170,961 (Direct)
SIMPSON TODD ECFO2012-08-27Sell45,00070,762$26.971213.6567.370,762 (Direct)
SIMPSON TODD ECFO2012-08-16Sell40,00050,762$25.971038.873.7450,762 (Direct)
DOBMEIER ERICCOO2012-08-13Sell25,00043,352$24.01600.2587.9243,352 (Direct)
SIEGALL CLAY BPresident and CEO2012-08-02Sell8,2501,096,711$26214.573.541,096,711 (Direct)
SIEGALL CLAY BPresident & CEO2012-07-02Sell8,2501,096,711$25.36209.2277.921,096,711 (Direct)
DOBMEIER ERICCOO2012-06-18Sell25,00068,073$25.3663477.9268,073 (Direct)
SIMPSON TODD ECFO2012-06-14Sell95,00050,762$24.52327.584.1650,762 (Direct)
ROSENBERG MORRISEVP, Process Sciences2012-06-12Sell10,00017,643$242408817,643 (Direct)
SIMPSON TODD ECFO2012-06-08Sell35,00050,762$22.97803.9596.4350,762 (Direct)
ROSENBERG MORRISEVP, Process Sciences2012-06-07Sell13,56617,643$22.5305.24100.5317,643 (Direct)
GRYSKA DAVID WDirector2012-06-05Sell8,00011,500$19.75158128.4611,500 (Direct)
ROSENBERG MORRISEVP, Process Sciences2012-05-18Sell65,00017,643$21.541400.1109.4717,643 (Direct)
Reynolds Thomas CChief Medical Officer2012-05-15Sell94931,073$19.7518.74128.4631,073 (Direct)
Reynolds Thomas CChief Medical Officer2012-04-25Sell40,00031,073$19.75790128.4631,073 (Direct)
DOBMEIER ERICCOO2012-04-25Sell25,00068,073$19.95498.75126.1768,073 (Direct)
ROSENBERG MORRISEVP, Process Sciences2012-04-20Sell38,28117,643$19.51746.86131.2717,643 (Direct)
ROSENBERG MORRISEVP, Process Sciences2012-04-17Sell44,21917,643$18.88834.85138.9817,643 (Direct)
Reynolds Thomas CChief Medical Officer2012-03-22Sell40,00031,073$19.78791.2128.1131,073 (Direct)
Reynolds Thomas CChief Medical Officer2012-03-19Sell40,00031,073$19.75790128.4631,073 (Direct)
ROSENBERG MORRISEVP, Process Sciences2012-03-13Sell69,62617,643$18.591294.35142.7117,643 (Direct)
DOBMEIER ERICCOO2012-02-28Sell46,00072,073$18.52851.92143.6372,073 (Direct)
DOBMEIER ERICCOO2012-02-28Sell4,00068,073$18.5374.12143.568,073 (Direct)
Reynolds Thomas CChief Medical Officer2012-01-27Sell40,00030,169$19.75790128.4630,169 (Direct)
SIEGALL CLAY BPresident and CEO2012-01-03Sell15,0001,130,055$16.73250.95169.71,045,055 (Direct)
85,000 (by Trust)
GRYSKA DAVID WDirector2011-12-09Sell10,00015,000$18.09180.9149.4215,000 (Direct)
SIEGALL CLAY BPresident and CEO2011-12-01Sell15,0001,130,055$15.97239.55182.531,045,055 (Direct)
85,000 (by Trust)
SIEGALL CLAY BPresident and CEO2011-11-01Sell15,0001,130,055$21.89328.35106.121,045,055 (Direct)
85,000 (by Trust)
DOBMEIER ERICCOO2011-10-27Sell20,91859,327$21.95459.15105.5659,327 (Direct)
DOBMEIER ERICCOO2011-10-20Sell20,46159,327$20.58421.09119.2459,327 (Direct)
SIMPSON TODD ECFO2011-10-07Sell24,35049,242$21.97534.97105.3749,242 (Direct)
SIEGALL CLAY BPresident and CEO2011-10-04Sell15,0001,130,055$20.15302.25123.921,045,055 (Direct)
85,000 (by Trust)
SIEGALL CLAY BPresident and CEO2011-09-21Sell30,0001,130,055$20.12603.6124.251,045,055 (Direct)
85,000 (by Trust)
14159 capital (GP), LLCDirector, 10% Owner2011-09-06Buy1,773323,148$17.0830.28164.17
323,148 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-09-06Buy129,18714,776,080$17.082206.51164.17
14,776,080 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-08-25Buy1,165,43514,646,893$15.3817924.39193.37
14,646,893 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-08-25Buy17,926321,375$15.38275.7193.37
321,375 (Through Partnership)
Reynolds Thomas CChief Medical Officer2011-08-01Sell1,5391,488$17.3726.73159.761,488 (Direct)
SIEGALL CLAY BPresident and CEO2011-07-01Sell15,0001,035,667$20.66309.9118.39950,667 (Direct)
85,000 (by Trust)
BERGER FRANKLIN MDirector2011-06-22Buy7,000163,720$20.04140.28125.15163,720 (Direct)
SIEGALL CLAY BPresident and CEO2011-06-20Sell9,0001,035,667$20.01180.09125.49950,667 (Direct)
85,000 (by Trust)
DOBMEIER ERICCOO2011-06-20Sell13,3858,817$20267.7125.68,817 (Direct)
SIEGALL CLAY BPresident and CEO2011-06-09Sell1,0001,035,667$2020125.6950,667 (Direct)
85,000 (by Trust)
DOBMEIER ERICChief Business Officer2011-06-09Sell3,60022,202$2072125.622,202 (Direct)
SIMPSON TODD ECFO2011-06-07Sell10,7509,359$19.96214.57126.059,359 (Direct)
ROSENBERG MORRISEVP, Process Sciences2011-06-07Sell2,5030$19.6749.23129.38Link
ROSENBERG MORRISEVP, Process Sciences2011-05-27Sell17,4970$19.5341.19131.38Link
Reynolds Thomas CChief Medical Officer2011-05-19Sell19,9983,027$18.71374.16141.153,027 (Direct)
ROSENBERG MORRISEVP, Process Sciences2011-05-19Sell20,0000$18.8376140Link
SIMPSON TODD ECFO2011-05-18Sell21,2509,359$18.64396.1142.069,359 (Direct)
ROSENBERG MORRISEVP, Process Sciences2011-05-13Sell20,0000$17.8356153.48Link
Reynolds Thomas CChief Medical Officer2011-05-13Sell20,0003,027$17.8356153.483,027 (Direct)
DOBMEIER ERICChief Business Officer2011-05-13Sell42,71525,802$18768.87150.6725,802 (Direct)
SIEGALL CLAY BPresident and CEO2011-05-09Sell50,0001,030,667$17.35867.5160.06945,667 (Direct)
85,000 (by Trust)
SIMPSON TODD ECFO2011-05-09Sell20,0009,359$17.74354.8154.349,359 (Direct)
SIEGALL CLAY BPresident and CEO2011-05-02Sell50,0000$17.43871.5158.86Link
ROSENBERG MORRISEVP, Process Sciences2011-05-02Sell25,0000$17.15428.75163.09Link
SIMPSON TODD ECFO2011-04-29Sell15,0000$16.94254.1166.35Link
Reynolds Thomas CChief Medical Officer2011-04-29Sell11,9150$16.95201.96166.19Link
SIEGALL CLAY BPresident and CEO2011-04-14Sell50,0000$15.27763.5195.48Link
SIEGALL CLAY BPresident and CEO2011-04-07Sell50,0000$16.06803180.95Link
DOBMEIER ERICChief Business Officer2011-04-05Sell40,0000$16640182Link
SIEGALL CLAY BPresident and CEO2011-03-17Sell200,0000$14.092818220.23Link
14159 capital (GP), LLCDirector, 10% Owner2011-02-02Buy48,1970$15.5747.05191.1Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-02-02Buy1,751,80313,470,692$15.527152.95191.1
13,470,692 (Through Partnership)
ROSENBERG MORRISEVP, Process Sciences2010-12-15Sell25,0000$16.22405.5178.18Link
ROSENBERG MORRISEVP, Process Sciences2010-12-02Sell25,0000$15.81395.25185.39Link
ROSENBERG MORRISEVP, Process Sciences2010-11-04Sell25,0000$14.7367.5206.94Link
Reynolds Thomas CChief Medical Officer2010-10-11Sell25,0005,719$16.95423.75166.19Link
Reynolds Thomas CChief Medical Officer2010-09-27Sell25,0005,719$14.95373.75201.81Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-06-08Buy599,06911,718,889$11.947152.88277.89Link
14159 capital (GP), LLCDirector, 10% Owner2010-06-08Buy16,536255,252$11.94197.44277.89Link
LIPPMAN MARC EDirector2010-06-04Buy20,000103,575$12.49249.8261.25Link
14159 capital (GP), LLCDirector, 10% Owner2010-05-25Buy150238,716$11.951.79277.57Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-05-25Buy5,41611,119,820$11.9564.72277.57Link
BERGER FRANKLIN MDirector2010-05-13Buy5,000138,720$13.3766.85237.47Link
LIPPMAN MARC EDirector2010-05-10Buy11,07583,575$11.92132.01278.52Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-05-04Buy561,70911,114,404$12.797184.26252.78Link
14159 capital (GP), LLCDirector, 10% Owner2010-05-04Buy15,506238,566$12.79198.32252.78Link
Reynolds Thomas CChief Medical Officer2010-05-03Sell25,0004,508$12.95323.75248.42Link
14159 capital (GP), LLCDirector, 10% Owner2010-04-30Buy51,581223,060$11.06570.49307.96Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-04-30Buy1,868,68610,552,695$11.0620667.67307.96Link
BERGER FRANKLIN MDirector2010-03-30Buy11,500116,720$12.05138.58274.44Link
BERGER FRANKLIN MDirector2010-03-12Buy13,000105,220$11.9154.7279.16Link
AKKARAJU SRINIVASDirector2009-08-18Buy4,90510,405$11.4756.26293.37Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2009-08-11Buy273,4044,626,213$10.752939.09319.72Link
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-08-11Buy798481,890$10.758.58319.72Link
Reynolds Thomas CChief Medical Officer2009-07-30Sell25,0003,713$12.47311.75261.83Link
DOBMEIER ERICChief Business Officer2009-07-30Sell60,00012,206$12.36741.6265.05Link
ROSENBERG MORRISEVP, Development2009-07-28Sell25,0000$11.81295.25282.05Link
AKKARAJU SRINIVASDirector2009-06-25Buy5,5005,500$9.2150.66389.9
Baker Biotech Capital (GP), LLDirector, 10% Owner2009-05-20Buy378,0534,352,809$9.723674.68364.2
Baker Brothers Life Sciences CDirector, 10% Owner2009-05-20Buy746,5718,684,009$9.727256.67364.2
14159 capital (GP), LLCDirector, 10% Owner2009-05-20Buy14,576171,479$9.72141.68364.2
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-05-20Buy3,710481,092$9.7236.06364.2
Baker / Tisch Capital (GP), LLDirector, 10% Owner2009-05-20Buy35,253400,898$9.72342.66364.2
DOBMEIER ERICChief Business Officer2008-09-26Sell24,4279,000$11.53281.64291.33
AKKARAJU SRINIVASDirector2008-09-22Sell18,601600,559$12.79237.91252.78
Reynolds Thomas CChief Medical Officer2008-09-22Sell12,3092,626$12.52154.11260.38
AKKARAJU SRINIVASDirector2008-09-19Sell37,011603,588$12.74471.52254.16
AKKARAJU SRINIVASDirector2008-09-19Sell87,696603,588$12.741117.25254.16
AKKARAJU SRINIVASDirector2008-09-18Sell20,839617,871$12.71264.86255
AKKARAJU SRINIVASDirector2008-09-18Sell49,378617,871$12.71627.59255
DOBMEIER ERICChief Business Officer2008-09-16Sell30,00033,427$12.25367.5268.33
ROSENBERG MORRISSr. VP, Development2008-08-04Sell50,0000$11.3565299.29
AKKARAJU SRINIVASDirector2008-07-29Sell95,688625,913$10.851038.21315.85
AKKARAJU SRINIVASDirector2008-07-28Sell21,232685,702$10.36219.96335.52
H&Q Holdings, Inc.10% Owner2008-07-28Sell21,50025,052$10.36222.74335.52
SIEGALL CLAY BPresident and CEO, Director2008-07-25Sell100,000953,168$10.781078318.55
H&Q Holdings, Inc.10% Owner2008-07-25Sell150,00025,186$10.811621.5317.39
JP MORGAN PARTNERS BHCA LP10% Owner2008-07-25Sell150,00025,186$10.811621.5317.39
AKKARAJU SRINIVASDirector2008-07-25Sell148,136701,432$10.811601.35317.39
JP MORGAN PARTNERS BHCA LP10% Owner2008-07-25Sell21,50025,052$10.36222.74335.52
AKKARAJU SRINIVASDirector2008-05-16Sell42,059811,175$10.39436.99334.26
AKKARAJU SRINIVASDirector2008-05-15Sell98,758842,334$10.141001.41344.97
JP MORGAN PARTNERS BHCA LP10% Owner2008-05-15Sell100,00026,383$10.141014344.97
H&Q Holdings, Inc.10% Owner2008-05-14Sell122,89327,004$10.11241.22346.73
JP MORGAN PARTNERS BHCA LP10% Owner2008-05-14Sell122,89327,004$10.11241.22346.73
AKKARAJU SRINIVASDirector2008-05-14Sell121,365915,496$10.11225.79346.73
H&Q Holdings, Inc.10% Owner2008-05-13Sell51,53627,768$10.06518.45348.51
JP MORGAN PARTNERS BHCA LP10% Owner2008-05-13Sell51,53627,768$10.06518.45348.51
AKKARAJU SRINIVASDirector2008-05-13Sell50,8961,005,407$10.06512.01348.51
Baker Biotech Capital (GP), LLDirector, 10% Owner2008-03-18Buy41,6663,974,756$7.9329.16471.14
14159 capital (GP), LLCDirector, 10% Owner2008-03-18Buy3,918156,903$7.930.95471.14
Baker Brothers Life Sciences CDirector, 10% Owner2008-03-18Buy123,4937,937,438$7.9975.59471.14
Baker Bros. Capital (GP), LLCDirector, 10% Owner2008-03-17Buy189477,241$7.81.47478.46
Baker Biotech Capital (GP), LLDirector, 10% Owner2008-03-14Buy65,0043,933,090$8.04522.63461.19
Baker Bros. Capital (GP), LLCDirector, 10% Owner2008-03-14Buy361477,052$8.072.91459.11
Baker / Tisch Capital (GP), LLDirector, 10% Owner2008-03-14Buy819365,645$8.046.58461.19
Baker Bros. Capital (GP), LLCDirector, 10% Owner2008-03-14Buy361477,052$8.072.91459.11
Baker Brothers Life Sciences CDirector, 10% Owner2008-03-14Buy173,4077,813,945$8.041394.19461.19
14159 capital (GP), LLCDirector, 10% Owner2008-03-14Buy5,503152,985$8.0444.24461.19
Baker / Tisch Capital (GP), LLDirector, 10% Owner2008-02-11Buy1,158364,826$9.0310.46399.67
Baker Bros. Capital (GP), LLCDirector, 10% Owner2008-02-11Buy177476,588$9.031.6399.67
Baker Biotech Capital (GP), LLDirector, 10% Owner2008-02-11Buy34,6533,868,086$9.01312.22400.78
Baker Brothers Life Sciences CDirector, 10% Owner2008-02-11Buy153,5387,640,538$9.011383.38400.78
14159 capital (GP), LLCDirector, 10% Owner2008-02-11Buy4,883147,482$9.0144400.78
Baker Bros. Capital (GP), LLCDirector, 10% Owner2008-01-23Buy5,006476,173$945.05401.33
Baker / Tisch Capital (GP), LLDirector, 10% Owner2008-01-23Buy43,170363,668$8.99388.1401.89
Baker Brothers Life Sciences CDirector, 10% Owner2008-01-23Buy2,094,2787,487,000$8.9918827.56401.89
14159 capital (GP), LLCDirector, 10% Owner2008-01-23Buy67,001142,599$8.99602.34401.89
Baker Biotech Capital (GP), LLDirector, 10% Owner2008-01-22Buy578,9163,833,433$8.995204.45401.89
BERGER FRANKLIN MDirector2008-01-22Buy52872,220$9.124.82394.74
JP MORGAN PARTNERS BHCA LP10% Owner2007-12-10Sell21,22428,088$12.63268.06257.24
AKKARAJU SRINIVASDirector2007-12-10Sell20,9601,043,112$12.63264.72257.24
SIMPSON TODD ECFO2007-09-26Sell32,2500$11.91384.1278.84
ROSENBERG MORRISSr. VP, Development2007-09-26Sell15,0000$11.93178.95278.21
DOBMEIER ERICChief Business Officer2007-09-20Sell1,9003,798$11.922.61279.16
DOBMEIER ERICChief Business Officer2007-09-20Sell19,1003,798$11.8225.38282.37
DOBMEIER ERICChief Business Officer2007-09-20Sell16,5003,798$11.65192.23287.3
DOBMEIER ERICChief Business Officer2007-09-20Sell18,1003,798$11.61210.14288.63
DOBMEIER ERICChief Business Officer2007-09-19Sell44,4003,798$11.54512.38290.99
LIPPMAN MARC EDirector2007-09-17Buy2,00010,000$10.6221.24324.86
SIEGALL CLAY BPresident and CEO2007-08-22Sell74,0001,053,168$11.09820.66306.85
SIEGALL CLAY BPresident and CEO2007-08-21Sell65,7001,127,168$10.99722.04310.56
SIEGALL CLAY BPresident and CEO2007-08-21Sell110,3001,079,168$11.141228.74305.03
TrailSmith Pamela AChief Scientific Officer2007-05-17Sell59,8916,940$10.23612.68341.06
ROSENBERG MORRISSr. VP, Development2007-05-17Sell25,0000$10.32258337.21
ROSENBERG MORRISSr. VP, Development2007-04-27Sell25,0000$9.54238.5372.96
Baker Bros. Capital (GP), LLCDirector2007-02-14Sell149,9304,957$8.761313.39415.07
Baker Biotech Capital (GP), LLDirector2007-02-14Sell999,7821,153,217$8.768758.09415.07
14159 capital (GP), LLCDirector2007-02-14Sell19,56175,598$8.76171.35415.07
Baker Brothers Life Sciences CDirector2007-02-14Sell1,599,7923,474,819$8.7614014.18415.07
Baker / Tisch Capital (GP), LLDirector2007-02-14Sell102,9353,998$8.76901.71415.07
14159 capital (GP), LLCDirector2007-02-14Sell19,56175,598$8.72170.57417.43
Baker Biotech Capital (GP), LLDirector2007-02-14Sell999,7821,153,217$8.728718.1417.43
Baker Bros. Capital (GP), LLCDirector2007-02-14Sell149,9304,957$8.721307.39417.43
Baker Brothers Life Sciences CDirector2007-02-14Sell1,599,7923,474,819$8.7213950.19417.43
AKKARAJU SRINIVASDirector2007-02-09Sell2,015,0000$8.5717268.55426.49
DOBMEIER ERICSr. VP, Corporate Development2007-02-09Sell50,0001,798$8.94447404.7
14159 capital (GP), LLCDirector, 10% Owner2006-08-14Buy85095,159$4.053.441014.07Link
Baker Brothers Life Sciences CDirector, 10% Owner2006-08-14Buy37,0704,149,611$4.05150.131014.07Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2006-08-14Buy12,0801,535,999$4.0548.921014.07Link
Baker Brothers Life Sciences CDirector, 10% Owner2006-08-11Buy110,2194,112,541$4.03444.181019.6Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2006-08-11Buy35,9171,523,919$4.03144.751019.6Link
14159 capital (GP), LLCDirector, 10% Owner2006-08-11Buy2,52994,309$4.0310.191019.6Link
14159 capital (GP), LLCDirector, 10% Owner2006-08-09Buy4,65291,239$4.0518.841014.07Link
Baker Brothers Life Sciences CDirector, 10% Owner2006-08-09Buy202,7613,978,746$4.05821.181014.07Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2006-08-09Buy66,0731,480,319$4.05267.61014.07Link
14159 capital (GP), LLCDirector, 10% Owner2006-08-07Buy1,49286,587$4.036.011019.6Link
Baker Brothers Life Sciences CDirector, 10% Owner2006-08-07Buy65,0203,775,985$4.03262.031019.6Link
Baker Brothers Life Sciences CDirector, 10% Owner2006-08-02Buy23,5763,734,541$3.787.231119.46Link
14159 capital (GP), LLCDirector, 10% Owner2006-08-02Buy54185,636$3.721119.46Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2006-08-02Buy7,6831,400,741$3.728.431119.46Link
14159 capital (GP), LLCDirector, 10% Owner2006-06-29Buy8,43585,095$4.0333.991019.6Link
Baker Brothers Life Sciences CDirector, 10% Owner2006-06-29Buy392,8333,710,965$4.031583.121019.6Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2006-06-29Buy129,9821,393,058$4.03523.831019.6Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2006-06-26Buy50,5351,263,076$4.02203.151022.39Link
Baker Brothers Life Sciences CDirector, 10% Owner2006-06-26Buy152,9413,318,132$4.02614.821022.39Link
14159 capital (GP), LLCDirector, 10% Owner2006-06-26Buy3,29776,660$4.0213.251022.39Link
Baker Brothers Life Sciences CDirector, 10% Owner2006-06-21Buy115,7053,165,191$4.02465.131022.39Link
14159 capital (GP), LLCDirector, 10% Owner2006-06-21Buy2,49473,363$4.0210.031022.39Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2006-06-21Buy38,2321,212,541$4.02153.691022.39Link
14159 capital (GP), LLCDirector, 10% Owner2006-06-13Buy33,07870,869$4132.311028Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2006-06-13Buy507,0211,174,309$42028.081028Link
Baker Brothers Life Sciences CDirector, 10% Owner2006-06-13Buy1,534,4433,049,486$46137.771028Link
Baker Brothers Life Sciences CDirector, 10% Owner2006-05-24Buy832,1351,515,043$5.254368.71759.43Link
14159 capital (GP), LLCDirector, 10% Owner2006-05-24Buy18,23037,791$5.2595.71759.43Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2006-05-24Buy278,650667,288$5.251462.91759.43Link
SIEGALL CLAY BPresident and CEO2005-09-13Sell73,0001,086,500$5.97435.81655.78Link
SIEGALL CLAY BPresident and CEO2005-09-09Sell24,0001,159,500$5.99143.76653.26Link
SIEGALL CLAY BPresident and CEO2005-08-02Sell103,0001,183,500$5.96613.88657.05Link
CARROLL TIMCFO2005-05-05Sell86,50062,861$5432.5802.4Link
Baker / Tisch Capital (GP), LLDirector, 10% Owner2005-05-04Buy67826,933$4.793.25841.96Link
Baker Biotech Capital II (Z) (Director, 10% Owner2005-05-04Buy94849,807$4.794.54841.96Link
Baker Biotech Capital III (Z) Director, 10% Owner2005-05-04Buy1,22245,090$4.795.85841.96Link
Baker Biotech Capital III (GP)Director, 10% Owner2005-05-04Buy6,305234,861$4.7930.2841.96Link
Baker Biotech Capital II (GP),Director, 10% Owner2005-05-04Buy6,627353,150$4.7931.74841.96Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2005-05-04Buy7,241388,638$4.7934.68841.96Link
Baker Bros. Capital (GP), LLCDirector, 10% Owner2005-05-04Buy1,44876,887$4.796.94841.96Link
14159 capital (GP), LLCDirector, 10% Owner2005-05-04Buy53119,561$4.792.54841.96Link
14159 capital (GP), LLCDirector, 10% Owner2005-04-29Buy6,39319,030$425.571028Link
Baker / Tisch Capital (GP), LLDirector, 10% Owner2005-04-29Buy8,41026,255$433.641028Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2005-04-29Buy89,394381,397$4357.581028Link
Baker Biotech Capital III (Z) Director, 10% Owner2005-04-29Buy14,73443,868$458.941028Link
Baker Bros. Capital (GP), LLCDirector, 10% Owner2005-04-29Buy17,76675,439$471.061028Link
Baker Biotech Capital II (Z) (Director, 10% Owner2005-04-29Buy11,54248,859$446.171028Link
Baker Biotech Capital III (GP)Director, 10% Owner2005-04-29Buy76,759228,556$4307.041028Link
Baker Biotech Capital II (GP),Director, 10% Owner2005-04-29Buy81,750346,523$43271028Link
BAKER BIOTECH CAPITAL GP LLCDirector, 10% Owner2005-03-30Buy12,040292,003$4.9659.72809.68Link
BAKER BIOTECH CAPITAL II GP LLDirector, 10% Owner2005-03-30Buy10,816264,773$4.9653.65809.68Link
BAKER TISCH CAPITAL GP LLCDirector, 10% Owner2005-03-30Buy1,13417,845$4.965.62809.68Link
BAKER BROS CAPITAL GP LLCDirector, 10% Owner2005-03-30Buy2,34457,673$4.9611.63809.68Link
Baker Biotech Capital II (Z) (Director, 10% Owner2005-03-30Buy1,50637,317$4.967.47809.68Link
Baker Biotech Capital III (GP)Director, 10% Owner2005-03-30Buy9,617151,797$4.9647.7809.68Link
Baker Biotech Capital III (Z) Director, 10% Owner2005-03-30Buy1,84329,134$4.969.14809.68Link
14159 Capital (GP, LLCDirector, 10% Owner2005-03-30Buy80012,637$4.963.97809.68Link
BAKER TISCH CAPITAL GP LLCDirector, 10% Owner2005-03-29Buy96816,711$4.884.72824.59Link
BAKER BROS CAPITAL GP LLCDirector, 10% Owner2005-03-29Buy2,00155,329$4.889.76824.59Link
Baker Biotech Capital II (Z) (Director, 10% Owner2005-03-29Buy1,28535,811$4.886.27824.59Link
BAKER BIOTECH CAPITAL II GP LLDirector, 10% Owner2005-03-29Buy9,229253,957$4.8845.04824.59Link
BAKER BIOTECH CAPITAL GP LLCDirector, 10% Owner2005-03-29Buy10,273279,963$4.8850.13824.59Link
Baker Biotech Capital III (GP)Director, 10% Owner2005-03-29Buy8,205142,180$4.8840.04824.59Link
Baker Biotech Capital III (Z) Director, 10% Owner2005-03-29Buy1,57327,291$4.887.68824.59Link
14159 Capital (GP, LLCDirector, 10% Owner2005-03-29Buy68211,837$4.883.33824.59Link
BAKER TISCH CAPITAL GP LLCDirector, 10% Owner2005-03-23Buy15,74315,743$4.9978.56804.21Link
BAKER BIOTECH CAPITAL II GP LLDirector, 10% Owner2005-03-23Buy150,679244,728$4.99751.89804.21Link
BAKER BIOTECH CAPITAL GP LLCDirector, 10% Owner2005-03-23Buy167,773269,690$4.99837.19804.21Link
BAKER BROS CAPITAL GP LLCDirector, 10% Owner2005-03-23Buy32,67053,328$4.99163.02804.21Link
Baker Biotech Capital II (Z) (Director, 10% Owner2005-03-23Buy20,98434,526$4.99104.71804.21Link
Baker Biotech Capital III (GP)Director, 10% Owner2005-03-23Buy63,376133,975$4.96314.34809.68Link
14159 Capital (GP, LLCDirector, 10% Owner2005-03-23Buy5,25111,155$4.9626.04809.68Link
Baker Biotech Capital III (Z) Director, 10% Owner2005-03-23Buy12,16625,718$4.9660.34809.68Link
POWELL MICHAELDirector2004-12-16Sell56,500685,892$7395.5544.57Link
POWELL MICHAELDirector2004-12-07Sell22,450742,392$7.03157.82541.82Link
POWELL MICHAELDirector2004-12-06Sell135,000764,842$7.06953.1539.09Link
POWELL MICHAELDirector2004-12-01Sell32,500899,842$6.94225.55550.14Link
POWELL MICHAELDirector2004-11-16Sell54,000932,342$6.9372.6553.91Link
POWELL MICHAELDirector2004-11-15Sell146,000986,342$6.77988.42566.47Link
POWELL MICHAELDirector2004-09-29Sell50,0001,131,354$6.67333.5576.46Link
POWELL MICHAELDirector2004-09-24Sell10,0001,181,354$6.9269.2552.02Link
POWELL MICHAELDirector2004-09-23Sell94,4881,191,354$6.83645.35560.61Link
POWELL MICHAELDirector2004-09-17Sell55,5001,285,842$6.71372.41572.43Link
POWELL MICHAELDirector2004-09-02Sell26,0001,341,342$6.61171.86582.6Link
POWELL MICHAELDirector2004-08-27Sell35,0001,367,342$6.81238.35562.56Link
POWELL MICHAELDirector2004-08-24Sell121,0001,402,342$6.81824.01562.56Link
POWELL MICHAELDirector2004-08-19Sell44,0001,523,342$6.75297568.44Link
BAKER BIOTECH CAPITAL GP LLCDirector, 10% Owner2004-08-12Buy32,72392,120$5.55181.61712.97Link
BAKER BIOTECH CAPITAL II GP LLDirector, 10% Owner2004-08-12Buy45,745188,823$5.49251.14721.86Link
BAKER BROS CAPITAL GP LLCDirector, 10% Owner2004-08-12Buy17,65029,619$5.495.31735.56Link
BAKER BIOTECH CAPITAL II GP LLDirector, 10% Owner2004-08-06Buy21,88962,682$5.53121.05715.91Link
BAKER BROS CAPITAL GP LLCDirector, 10% Owner2004-08-06Buy4,21311,969$5.5323.3715.91Link
BAKER BIOTECH CAPITAL GP LLCDirector, 10% Owner2004-08-06Buy20,73459,397$5.53114.66715.91Link
BAKER BIOTECH CAPITAL GP LLCDirector, 10% Owner2004-08-04Buy38,66338,663$5.72221.15688.81Link
BAKER BIOTECH CAPITAL II GP LLDirector, 10% Owner2004-08-04Buy40,79340,793$5.72233.34688.81Link
BAKER BROS CAPITAL GP LLCDirector, 10% Owner2004-08-04Buy7,7567,756$5.7244.36688.81Link
POWELL MICHAELDirector2004-06-29Sell28,5001,567,342$7.03200.36541.82Link
CARROLL TIMCFO2004-06-28Sell60,000152,361$7.04422.4540.91Link
POWELL MICHAELDirector2004-06-25Sell121,5001,595,842$7.08860.22537.29Link
POWELL MICHAELDirector2004-06-22Sell80,0001,717,342$7.12569.6533.71Link
CARROLL TIMCFO2004-05-10Sell8,600212,361$8.2270.69448.91Link
DOBMEIER ERICV. P., Corporate Affairs2004-05-05Sell15,000300$8.59128.85425.26Link
POWELL MICHAELDirector2004-03-09Sell65,0001,797,342$10.42677.3333.01Link
POWELL MICHAELDirector2003-12-30Sell7,0001,862,342$8.962.3406.97Link
POWELL MICHAELDirector2003-12-23Sell87,2501,869,342$7.22629.95524.93Link
POWELL MICHAELDirector2003-12-09Sell56,0001,956,592$7.02393.12542.74Link
CARROLL TIMCFO2003-12-05Sell80,000220,961$6.63530.4580.54Link
POWELL MICHAELDirector2003-12-04Sell11,7032,012,592$6.5676.77587.8Link
POWELL MICHAELDirector2003-12-02Sell153,0002,024,295$6.33968.49612.8Link
SIEGALL CLAY BPresident and CEO2003-12-02Sell50,0001,291,500$6.47323.5597.37Link
FELL H PERRYChairman2003-12-02Sell50,0001,294,000$6.47323.5597.37Link
SIEGALL CLAY BPresident and CEO2003-11-26Sell4,5001,341,500$6.4428.98600.62Link
FELL H PERRYChairman2003-11-26Sell4,5001,344,000$6.4428.98600.62Link
POWELL MICHAELDirector2003-11-26Sell108,5002,177,295$6.27680.3619.62Link
SIEGALL CLAY BPresident and CEO2003-11-24Sell56,5001,346,000$6.52368.38592.02Link
FELL H PERRYChairman2003-11-24Sell56,5001,348,500$6.52368.38592.02Link
HELLSTROM KARL ERIKDirector2003-11-19Sell66,500700,000$6.69444.89574.44Link
POWELL MICHAELDirector2003-11-18Sell414,4782,285,795$62486.87652Link
HELLSTROM KARL ERIKDirector2003-11-18Sell133,500766,500$6.48865.08596.3Link
SIEGALL CLAY BPresident and CEO2003-09-15Sell10,0001,402,500$5.959664.75Link
FELL H PERRYChairman2003-09-15Sell10,0001,405,000$5.959664.75Link
SIEGALL CLAY BPresident and CEO2003-09-11Sell47,5001,412,500$6.05287.38645.79Link
FELL H PERRYChairman2003-09-11Sell47,5001,415,000$6.05287.38645.79Link
SIEGALL CLAY BPresident and CEO2003-09-08Sell31,5001,460,000$6.18194.67630.1Link
FELL H PERRYChairman2003-09-08Sell31,5001,462,500$6.18194.67630.1Link
SENTER PETERVice President, Chemistry2003-08-21Sell19,60068,148$5.27103.29756.17Link
SING AMYSr. Director Medical Affairs2003-08-18Sell20,00052,107$5.09101.8786.44Link
LIPPMAN MARC EDirector2003-08-14Buy15,00052,500$4.8873.2824.59Link
SING AMYSr. Director Medical Affairs2003-08-04Sell5,00072,107$4.723.5860Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

"Shares" change (fifth column), "Shares Owned Following This (Direct & Indirect)" transactions (sixth column), and "Trade Price ($)" (seventh column) are split adjusted. The "Share Ownership Details" (last column) displayed data is as of reported (also split adjusted).

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK